West Caldwell, NJ, United States of America

Alan B Cooper

This inventor holds 44 USPTO granted patents and 2 published patent applications and 11 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Schering Corporation, Merck Sharp + Dohme Corp., Bantam Pharmaceutical, LLC. Active years: 1979-2026.

USPTO Granted Patents = 44 (Patent Applications = 2)

% Patents Active = 81.8

EPO Patents = 11 (Patent Applications = 13)

Average Co-Inventor Count = 5.9

ph-index = 11

Forward Citations = 310(Granted Patents)

Location History:

Parsippany, NJ (US) (1979)
Caldwell, NJ (US) (1994)
West Caldwell, NJ (US) (1980 - 2017)
Kenilworth, NJ (US) (2014 - 2023)

Company Filing History:

Merck Sharp + Dohme Corp.

patents

7 out of 8

Bantam Pharmaceutical, LLC

Merck Sharp + Dohme B.v.

where one patent can have more than one assignee

Years Active: 1979-2026

Loading Chart...

Areas of Expertise:

Pyrazole Compounds

ERK Inhibitors

Farnesyl Protein Transferase

Antitumor Agents

Antiviral Agents

Heterocyclic Compounds

Tricyclic Compounds

Anti-fungal Agents

Nikkomycin Analogs

Dioxolane Antifungal

Transition Metal Complexes

Carboxylic Acids

44 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12662477 - Substituted pyrazole compounds and methods of using them for treatment of hyperproliferative diseases (2026-06-23),

2. 12378234 - Crystalline polymorphs of a 1-thiazol-2-yl-pyrazole-5-carboxylic acid derivative (2025-08-05),

3. 12358905 - Methods for making thiazolypyrazole carboxylic acids and intermediates therefor (2025-07-15),

4. 12150934 - Methods of using substituted pyrazole and pyrazole compounds and for treatment of hyperproliferative diseases (2024-11-26),

5. 11602526 - Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating thereto (2023-03-14),

6. 11325903 - Substituted pyrazole compounds and methods of using them for treatment of hyperproliferative diseases (2022-05-10),

7. 10537558 - Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating thereto (2020-01-21),

8. 9718828 - BTK Inhibitors (2017-08-01),

9. 9351965 - Indazole derivatives useful as ERK inhibitors (2016-05-31),

10. 9242981 - Fused pyrazole derivatives as novel ERK inhibitors (2016-01-26),

11. 8999966 - Compounds that are ERK inhibitors (2015-04-07),

12. 8999957 - Heterocyclic compounds as ERK inhibitors (2015-04-07),

13. 8946216 - Indazole derivatives useful as ERK inhibitors (2015-02-03),

14. 8716483 - Compounds that are ERK inhibitors (2014-05-06),

15. 8658651 - Compounds that are ERK inhibitors (2014-02-25),

Title: The Innovative Mind of Alan B Cooper

Introduction: Alan B Cooper, a distinguished inventor hailing from West Caldwell, NJ, has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents: Alan B Cooper's latest patents include a revolutionary software application for enhancing cybersecurity measures in financial institutions and a cutting-edge wearable device that monitors vital health metrics in real-time.

Career Highlights: With over two decades of experience in the tech industry, Alan B Cooper has a proven track record of developing innovative solutions. He has held key positions in renowned tech companies, leading teams to create products that have redefined industry standards.

Collaborations: Throughout his career, Alan B Cooper has collaborated with top researchers, engineers, and designers to bring his ideas to life. His ability to work seamlessly in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: Alan B Cooper's passion for innovation, coupled with his technical expertise, has solidified his reputation as a trailblazer in the field of technology. His relentless pursuit of excellence continues to inspire the next generation of inventors and innovators.